Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression Following Erlotinib

NCT02431169 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02431169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02431169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression Following Erlotinib
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Terminated
Start date
April 30, 2015
Completion date
June 27, 2019
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell-lung, non-small cell lung cancer, nonsmall cell lung cancer